Table 4.

Lung cancer characteristics

Patient #	Months since transplant	Location of tumour native versus allograft	Location of tumour	Smoking history in pack-years	Nodule size (mm)	Histology	TNM staging	Treatment	Mortality	Length of follow-up in months
1	84	Allograft	RUL	18	14	EBV smooth muscle tumour	T1N0M0	Surgical	Yes	24
2	0	Allograft	RML, LUL	0	N/A	Adeno SCC	N/A	None	Yes	13
3	24	Native	LLL	90	10	SCC	T1aN2M0	Surgical, chemotherapy, radiation	Yes	8
4	46	Native	RUL	24	29	Adeno	T1cN0M1a	Chemotherapy	Yes	2
5	48	Allograft	RUL	0	N/A	Adeno	TxN2M1	None	Yes	1
6	13	Allograft	R hilum	180	N/A	Adeno	TxN3M0	None	Yes	1
7	22	Native	LLL	25	20	SCLC	T2N1M0	Surgical, chemotherapy	No	33
8	26	Native	RML	60	40	SCC	T2N0M0	Surgical	No	21
9	48	Native	RUL	41	43	SCC	T3N0M0	Surgical	No	9
10	44	Native	LUL	36	22	SCC	T1cN0M0	Surgical	No	7
11	14	Native	RUL	6.6	45	Adeno	T2aN3M1a	None	Yes	4
12	12	Native	R hilum	30	52	SCC	T4N2M1c	Chemotherapy, radiation	Yes	5
13	26	Allograft	L hilum and pericardium	35	62	SCC	T3N0M1c	None	Yes	<1
14	48	Native	LUL	57	23	Adeno	T1cN0M0	Radiation	Yes	9
15	14	Native	RUL	13	14	SCC	T1aN0M0	Surgical	No	30
16	24	Native	RUL	0	88	SCC	T4N0M1a	Radiation	Yes	2
17	6	Allograft	LUL	40	19	NSCLC	T1bN3M1a	None	Yes	3
18	37	Allograft	Right lung	25	N/A	Adeno	TxN3M1c	None	Yes	1
19	23	Native	LUL	40	79	SCC	T4N0M0	Chemotherapy, radiation	Yes	5
20	19	Native	LLL	7	30	SCC	T1cN0M0	SRS SBRT	No	8
21	30	Allograft	L hilum	80	N/A	NSCLC	N/A	None	No	19
22	0	Native	LUL	30	6	Adeno	T1cN0M0	Surgical resection	No	44
23	5	Native	LUL	80	25	SCLC	T3N1M1	Chemotherapy	Yes	6
24	40	Native	RLL	52	10	SCLC	T1cN1M1a	Chemotherapy	No	6

Adeno, adenocarcinoma; EBV, Epstein-Barr virus; N/A, not available; NSCLC, non-small cell lung cancer; SBRT, Stereotactic Body Radiotherapy; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; SRS, Stereotactic Radiosurgery; TNM, tumour, node, metastases.